Qlosi(Pilocarpine HCl ophthalmic solution 0.4%)
Acetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine Injection
Validity period:
24 months
Reminder: The outer packaging is for reference only, please purchase and use under the guidance of
a
pharmacist. For read by medical and pharmaceutical professionals only.
Qlosi(Pilocarpine HCl ophthalmic solution 0.4%) Instructions:Uses,Dosage, Side Effects
QLOSI is a sterile, slightly viscous ophthalmic solution with a strength of 0.4% pilocarpine hydrochloride (equivalent to 4 mg/mL). It is supplied in single-patient-use vials and functions as a cholinergic agonist targeting muscarinic receptors to improve near vision. Manufactured by Orasis Pharmaceuticals, it is stored refrigerated and discarded after each use.
Generic name
Qlosi(Pilocarpine HCl ophthalmic solution 0.4%)
English name
Pilocarpine HCl ophthalmic solution 0.4%
Indications
QLOSI is indicated for the treatment of presbyopia in adult patients.
Therapeutic Target
Muscarinic cholinergic receptors located in the iris sphincter and ciliary muscles.
Active Ingredients
Pilocarpine hydrochloride
Dosage and Administration
Instill one drop in each eye. A second drop may be administered after 2–3 hours for extended effect (up to 8 hours). May be used daily or as needed, up to twice daily. If using other topical ophthalmic agents, allow at least 5 minutes between applications. Discard vial after single use.
Contact Us
Mailbox:Info@Lucius.La
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved